A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.
about
Spironolactone for hypertensionAldosterone synthase inhibition in humansGraz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism.Management of hypertension in primary aldosteronismAldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas.New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension.Assessment of left ventricular function by two-dimensional speckle-tracking echocardiography in small breed dogs with hyperadrenocorticismAldosterone: a forgotten mediator of the relationship between psychological stress and heart diseaseGender differences in cardiovascular disease: hormonal and biochemical influences.Variable transcriptional regulation of the human aldosterone synthase gene causes salt-dependent high blood pressure in transgenic mice.A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systems.Cushing's Disease Presented by Reversible Dilated Cardiomyopathy.Lanosterol Synthase Gene Polymorphisms and Changes in Endogenous Ouabain in the Response to Low Sodium Intake.Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor.Progress in primary aldosteronism: present challenges and perspectivesReducing dietary sodium intake: the Canadian context.ACTH and Polymorphisms at Steroidogenic Loci as Determinants of Aldosterone Secretion and Blood Pressure.Primary hyperaldosteronism: expanding the diagnostic net.Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis.Steroidogenesis-adrenal cell signal transduction.Salt Sensitivity: Challenging and Controversial Phenotype of Primary Hypertension.Diagnosing endocrine hypertension: a practical approach.Vitamin D Attenuates Left Atrial Volume Changes in African American Males with Obesity and Prediabetes.Haplotype association and synergistic effect of human aldosterone synthase (CYP11B2) gene polymorphisms causing susceptibility to essential hypertension in Indian patients.The relationship between vitamin D deficiency and coronary artery ectasiaThe relationship among cardiac structure, dietary salt and aldosterone in patients with primary aldosteronism.Metabolic syndrome and primary aldosteronism: time for reappraisal?Captopril suppression: limitations for confirmation of primary aldosteronism.Alterations in vascular function in primary aldosteronism: a cardiovascular magnetic resonance imaging study.Central and Peripheral Slow-Pressor Mechanisms Contributing to.Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System.Histone deacetylase inhibition, but not a mineralocorticoid receptor antagonist spironolactone, attenuates atypical transcription by an activating mutant MR (MRS 810L ).Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease.Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
P2860
Q24236324-D767C3CA-BF36-4A8B-9BF3-120E6A2F23CFQ27016157-0E72D5A7-3D04-48B7-9E2B-FE95882E75BDQ33427667-4F37561E-BF7F-448D-BE9B-A0934EDD4361Q33772765-5040AA61-21E8-41CF-97FB-FDB688A2F04DQ33930728-A1DBD1C9-60BC-4CE5-9AEC-C55984AB740AQ34153759-98B005C7-C16B-4636-A78C-9D4122DB6DBBQ34384580-62AF338B-505E-4242-8AC8-1DCC332A39B8Q34988718-C1A124D6-B899-49B7-9413-97825335FC50Q34997222-8716575C-7B6B-4F3C-82E8-221826382C51Q35023822-66FF8DF4-BD5B-4551-A300-8DBD7747DFA7Q35102248-0910F1DB-109A-48F8-8047-3948F514676BQ36134787-55AAF5DD-A3FC-41E3-9B9E-21A75695FC24Q36328431-9FA2B5C0-7633-4C76-A90C-505277EABA82Q36328858-6645AD0A-9375-4F02-BAF9-68318A4E3244Q36463905-82141975-1ADE-48E0-A17D-BE7F9D3EF004Q36681464-6FDBA195-5608-4AA9-91AD-47909814A562Q37332443-3305E499-2C7A-4223-B8BE-28A762FFDF50Q37679032-A332F40C-9AE0-47E8-B65E-BEA5222449BBQ37687081-2F82CA9E-64AF-4677-B262-1EAAAED37EB7Q37729184-1203750C-3C53-47F8-A43C-51C36DE13104Q37923102-10C06A27-8204-46AA-A44E-FF87CB18EC07Q37984036-833DC064-5BD7-4D5D-9977-12D03BFE5E4DQ38132689-6E5664D7-6DBE-4F88-8EAF-16D07647464FQ38221447-30056A7C-35E9-46C9-B2AF-B20490709891Q38951008-478FA337-D519-4D4E-9324-9F9A79AC2738Q39337899-66A63851-2F71-431C-8B59-F35C47CA44C5Q40164715-74D59978-6026-4D91-B0DC-3465A4A80BBDQ40432878-B7651948-3621-4A50-B4F1-7413A25230C7Q41609159-75AE30D9-38C1-46B6-B17F-F8D69DA361B2Q42700680-B959CA83-3AD9-44B3-B726-D02F55DE01C0Q42969980-AAC007DC-7DAB-4217-A224-AE779345F5DEQ46141730-7A0056CC-F7E8-4245-9124-25EA9DBF4D42Q46665568-A6CD1510-08CD-4425-B043-442F6D8EADD8Q47416221-4F322215-7F16-49D7-85EF-FEE8D2CEAC9BQ47603197-F5B07F40-99CD-4003-8C3E-2F6A09C4DC7AQ47866992-C3574043-91F7-4695-908E-094C93E8BE54Q48181150-CECDDA72-DEC4-4E6D-BBD4-3B537F7FB84BQ50505430-4B78A795-B5EE-43DB-AE8C-4606EC7F244BQ51182332-42981927-A258-4CB5-B252-8E4DBA4566B6Q51464359-E33420BB-9EED-4B57-8A80-5150704F472E
P2860
A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A lifetime of aldosterone exce ...... n for cardiovascular function.
@en
A lifetime of aldosterone exce ...... n for cardiovascular function.
@nl
type
label
A lifetime of aldosterone exce ...... n for cardiovascular function.
@en
A lifetime of aldosterone exce ...... n for cardiovascular function.
@nl
prefLabel
A lifetime of aldosterone exce ...... n for cardiovascular function.
@en
A lifetime of aldosterone exce ...... n for cardiovascular function.
@nl
P2093
P356
P1433
P1476
A lifetime of aldosterone exce ...... n for cardiovascular function.
@en
P2093
E Marie Freel
Eleanor Davies
John M C Connell
Robert Fraser
Scott M MacKenzie
P304
P356
10.1210/ER.2007-0030
P577
2008-02-21T00:00:00Z